Journal article
Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma
Nicole Wong Doo, Philip A Thompson, H Miles Prince, John F Seymour, David Ritchie, Kerrie Stokes, Kate Burbury, Max Wolf, Trish Joyce, Simon J Harrison
Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2013
Grants
Funding Acknowledgements
S. Harrison has received research funding from Janssen-Cilag.